Alkaline Phosphatase (ALP), Serum
Alkaline phosphatase (ALP) belongs to a category of enzymes that primarily catalyze removal of phosphate esters. The enzyme is found in many tissues and is especially concentrated in the liver, bile duct, intestine, kidney, bone, and placental tissue. In a number of these tissues, the molecular form of the enzyme is distinctive, and isoenzyme evaluation can offer additional information to identify the cause of increased ALP levels. ALP is synthesized by biliary epithelium and excreted in bile. It is called alkaline as it functions only at alkaline pH.
More than 80% of this enzyme activity originates from liver and bone. Increased serum ALP levels provide useful but nonspecific indication of liver or bone disease. ALP levels increase with obstructive biliary excretion. Increased levels are also seen in hepatic and bone metastases. However, ALP levels are increased in normal physiological processes as well such as bone growth and fracture healing. ALP levels can be increased with alcohol use and in some inflammatory processes and pregnancy. To determine the origin of elevated ALP, isoenzymes by electrophoresis should be ordered.
- In conjunction with other liver functional testing (panel), it will help in diagnosis of liver diseases
- In evaluation of liver cancer and metastasis
- Evaluation of bone lesions and metastasis
- Monitor the treatment of liver and bone metastasis
- It is ordered in the panels used to monitor many diseases and disorders including rickets and osteomalacia, Paget’s disease of bone, hyperthyroidism, hyperparathyroidism, in chronic alcohol use, and for biliary obstruction
- It is used as a tumor marker of many tumors such as leukemia, myeloproliferative disorders, pancreatic tumors obstructing the common bile duct and osteogenic sarcomas
Increased in:
- Obstructive hepatobiliary disease
- Bone disease and physiologic bone growth
- Paget’s disease
- Osteomalacia
- Osteogenic sarcoma
- Bone metastases
- Bone disease
- Cushing's syndrome
- Hyperparathyroidism
- Rickets
- Benign familial hyperphosphatemia
- Pregnancy (third trimester)
- GI disease (perforated ulcer bowel infarct or inflammatory bowel disease)
- Liver disease including Hepatitis Hepatoma Abscess Cirrhosis Necrosis Liver metastasis Cholangitis
- Thyrotoxicosis
- Pancreatitis
- Lung or Kidney infarction
- Regan or Nagao isoenzyme
- Some hepatotoxic drugs
Decreased in:
- Hypophosphatasia
- Low magnesium level
- Hypothyroidism
- Scurvy
- B12 deficiency
- Lack of Zinc or mangesium in diet
To determine whether an elevated ALP is due to liver or bone, other testing can be done such as ALT, AST, GGT, 5'-nucleotidase, which if elevated indicate liver as the source. Conversely, if these are normal and serum calcium and phosphate are abnormal bone is the source.
Note: It is important to interpret the results of Alk Phos testing in the clinical context, particularly the age of the patient, as values vary considerably by age. The test should be correlated with other tests to determine the origin of an elevated value.
0-10 years: 100-350 IU/L
10-18 years: 110-500 IU/L
18 years-Adult: 38-137 IU/L
Enzymatic, spectrophotometric.
Serum (SST), Plasma EDTA (Lavender) or Heparin (Green).
Stability
- Ambient: 5-7 days
- Refrigerated: 7-14 days
- Frozen: 30 days
1-3 days.
- Indian J Pediatr. 2007 Jul;74(7):663-71. [PMID: 17699976]
- Clin Lab Med. 2002;22:377. [PMID: 12134466]
- Endocr Pract. 2006;12:676. [PMID: 17229666]
- Pediatr Rev. 2006;27:382. [PMID: 17012488]
- Alan Wu. Tietz Clinical Guide to Laboratory Tests, Fourth Edition. Saunders; 4 edition (June 13, 2006). ISBN-10: 0721679757.